Table 2.

Treatment Details in Both Groups (CONTROL and NOFS)

CONTROL (N = 1,896)NOFS (N = 102)P Value
Tumor volume (ccm)1.35 (± 1.88)1.57 (± 1.72)0.228
Conformity index (Paddick)0.76 (± 0.12)0.80 (± 0.26)0.127
Therapeutical dose (Gy)12.81 (± 0.45)12.85 (± 0.36)0.256
Isodose (%)62.16 (± 5.28)62.17 (± 5.36)0.987
Maximal dose (Gy)20.75 (± 1.72)20.81 (± 1.77)0.721
Mean dose (Gy)16.35 (± 0.92)17.06 (± 4.86)0.242
CONTROL (N = 1,896)NOFS (N = 102)P Value
Tumor volume (ccm)1.35 (± 1.88)1.57 (± 1.72)0.228
Conformity index (Paddick)0.76 (± 0.12)0.80 (± 0.26)0.127
Therapeutical dose (Gy)12.81 (± 0.45)12.85 (± 0.36)0.256
Isodose (%)62.16 (± 5.28)62.17 (± 5.36)0.987
Maximal dose (Gy)20.75 (± 1.72)20.81 (± 1.77)0.721
Mean dose (Gy)16.35 (± 0.92)17.06 (± 4.86)0.242
Table 2.

Treatment Details in Both Groups (CONTROL and NOFS)

CONTROL (N = 1,896)NOFS (N = 102)P Value
Tumor volume (ccm)1.35 (± 1.88)1.57 (± 1.72)0.228
Conformity index (Paddick)0.76 (± 0.12)0.80 (± 0.26)0.127
Therapeutical dose (Gy)12.81 (± 0.45)12.85 (± 0.36)0.256
Isodose (%)62.16 (± 5.28)62.17 (± 5.36)0.987
Maximal dose (Gy)20.75 (± 1.72)20.81 (± 1.77)0.721
Mean dose (Gy)16.35 (± 0.92)17.06 (± 4.86)0.242
CONTROL (N = 1,896)NOFS (N = 102)P Value
Tumor volume (ccm)1.35 (± 1.88)1.57 (± 1.72)0.228
Conformity index (Paddick)0.76 (± 0.12)0.80 (± 0.26)0.127
Therapeutical dose (Gy)12.81 (± 0.45)12.85 (± 0.36)0.256
Isodose (%)62.16 (± 5.28)62.17 (± 5.36)0.987
Maximal dose (Gy)20.75 (± 1.72)20.81 (± 1.77)0.721
Mean dose (Gy)16.35 (± 0.92)17.06 (± 4.86)0.242
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close